Stock upgrades today highlight ASNS BABA META RACE and more

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  02 Sep 2025
 

•   ALLY  
   
  +0.27%
•   ASNS  
   
  -8.51%
•   BABA  
   
  -1.52%
•   CHE  
   
  -0.94%
•   FEAM  
   
  -2.57%

$ALLY gained attention after Wells Fargo lifted its rating to Equal Weight, reflecting optimism that Fed rate cuts will ease funding costs for financials. Shares eased slightly, but the upgrade signals a more constructive view on Ally’s balance sheet resilience and lending potential in a softer rate environment.

$ASNS soared after securing a pivotal FAA order for its cyber-hardened networking solutions. This win positions Actelis at the core of a $12.5 billion aviation infrastructure modernization initiative, underscoring the company’s ability to deliver cost-efficient, rapid-deployment technology. With the stock surging over 26%, the market clearly sees this as a transformative moment.

$BABA drew fresh bullish sentiment as Benchmark reiterated its Buy rating and boosted its target to $195. Alibaba’s strengthening cloud division and renewed e-commerce momentum put the company in a prime position as Chinese tech consolidates around AI-driven growth. Shares rose more than 2%, showing confidence is building in its turnaround.

$CHE received a lift from Jefferies, upgrading the stock as Medicare cap risks ease and buybacks provide additional support. The stability of Chemed’s healthcare services, paired with shareholder-friendly capital allocation, gives investors more visibility on earnings durability.

$FEAM saw coverage initiation from H.C. Wainwright with a Buy rating, betting on the long-term need for advanced materials. Though lightly traded, the initiation shows a growing recognition of its potential in next-generation industrial applications.

$FNV continues to appeal as a defensive play in the gold space. Analysts see Franco-Nevada as a buy-the-dip candidate, offering leverage to gold while maintaining a clean balance sheet and stable cash flows.

$LITE drew a Buy initiation from Citi on the back of AI data center growth. With optical components becoming critical for hyperscale deployments, Lumentum is seen as a key beneficiary of this multi-year infrastructure cycle.

$LKFN was upgraded to Buy as optimism builds around earnings momentum. While the regional banking space faces headwinds, Lakeland’s financial discipline and consistent profitability give it relative strength.

$MDT held onto bullish backing with TD Cowen reaffirming a Buy, citing prospects in renal denervation (RDN) therapy. Medtronic’s pipeline strength offers potential upside as innovation translates into commercial opportunity.

$META received a high-profile upgrade at Morgan Stanley, with analyst Meta Marshall raising the stock to Overweight and lifting the target to $320. The call reflects confidence in Meta’s momentum across AI-driven initiatives and digital ad recovery, even as shares consolidated slightly today.

$MS earned an upgrade to Buy at Zacks, pointing to growing optimism around earnings prospects. Morgan Stanley’s diversified business model provides balance between wealth management, trading, and advisory, which could power shares higher despite today’s modest decline.

$PEN drew fresh coverage with a Buy rating, underscoring confidence in Penumbra’s growth trajectory in medical devices. Even with shares sliding today, analysts see strong market opportunities ahead.

$PFS was upgraded to Strong Buy at Zacks, citing earnings momentum. At under $20 a share, Provident Financial is being flagged as a value play within the regional financial space.

$POST was highlighted by Zacks for strong momentum as shares hit 52-week highs. Post Holdings’ cash flow strength and growth profile keep it on analysts’ radar.

$PRCH gained on Goldman Sachs initiating with a Buy rating, sending shares higher. Porch Group’s marketplace model and execution on home services expansion suggest significant upside if growth continues.

$RACE sped ahead after Deutsche Bank upgraded Ferrari, pointing to the upcoming F80 supercar as a major earnings catalyst. At €3.6 million apiece, this model could add hundreds of millions in incremental profit, solidifying Ferrari’s luxury moat.

$SNY was lifted by Deutsche Bank to Buy, with a €110 price target on Amlitelimab optimism. Sanofi’s pipeline strength makes it a contender in the biopharma sector, particularly with new therapies offering differentiation.

$THC saw its strong year-to-date rally reinforced with an upgraded outlook. With shares already up 46% YTD, Tenet Healthcare remains attractive on valuation relative to growth potential.

$UDMY was elevated to Strong Buy at Zacks, pointing to improving earnings momentum. While the stock dipped today, the platform’s long-term growth prospects in online education remain intact.

$ZS climbed on an upgrade from Morgan Stanley, which reinforced bullishness around Zscaler’s positioning in zero-trust cybersecurity and AI-enhanced capabilities. Even with shares slightly lower today, analysts see its platform strategy driving upside.

View All Headlines